However, the interaction between hs-cTnT level (elevated versus normal) and treatment group was borderline significant for the composite end point of death, stroke, or HFH (Pinteraction=0.06) and significant for the composite of death or HFH (Pinteraction=0.04) and HFH alone (Pinteraction=0.03; Figure 3). Here, TNNT2 is linked to stroke disorder.